Use of substituted amines for the treatment of brain function disorders
US5547965A · kind A · utility
4Cited by
29References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 19, 1995 |
| Grant date | Aug 20, 1996 |
| Priority date | — |
| Expiry date | Apr 19, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of substituted amines for the treatment and prevention of brain function disorders. The substituted amines are suitable on the basis of their properties as agonistic or antagonistic ligands for nicotinergic receptors, in particular for the treatment and prevention of senile and presenile dementia and dementia of the Alzheimer type, and of depressions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.